trending Market Intelligence /marketintelligence/en/news-insights/trending/SRvNe0Lv9THZeEANkRVFJQ2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

German court rules in favor of ResMed in Fisher & Paykel patent case

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


German court rules in favor of ResMed in Fisher & Paykel patent case

ResMed Inc. said the Munich District Court ruled in its favor in a patent infringement case against Fisher & Paykel Healthcare Corp. Ltd.

The German court found that ResMed's AirSense 10, AirCurve 10, Lumis and its humidifiers do not infringe Fisher & Paykel's patent for a German utility model.

Previously, the same German court said Fisher & Paykel's Simplus, Eson and Eson 2 masks infringe on ResMed's patents. However, it suspended two patent proceedings involving the two companies pending the result of invalidation proceedings.

ResMed intends to continue the patent challenge against Fisher & Paykel's German utility model before the German Patent and Trademark Office.

The company said the German ruling has no effect on their patent infringement cases against Fisher & Paykel in other jurisdictions.